| Jason David Litsky, DO | |
|
11 Meridian Rd, Eatontown, NJ 07724-2242 | |
| (732) 663-0300 | |
| (732) 663-0301 |
| Full Name | Jason David Litsky |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 19 Years |
| Location | 11 Meridian Rd, Eatontown, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114169539 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0011X | Internal Medicine - Interventional Cardiology | 25MB09435600 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jersey Shore University Medical Center | Neptune, NJ | Hospital |
| Centrastate Medical Center | Freehold, NJ | Hospital |
| Bayshore Medical Center | Holmdel, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Monmouth Cardiology Associates, Llc | 6901881200 | 39 |
News Archive
IntraPace, Inc., the developer of the innovative abiliti implantable obesity management system, announced today that it will launch its new lifestyle management portal and support network this week at the XVI World Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) in Hamburg, Germany.
Publication in Nature Cell Biology advanced on line publication: researchers at the Université Libre de Bruxelles, ULB identify multipotent and unipotent Stem Cells (SCs) that contribute to prostate postnatal development.
A study published this week in Genetics in Medicine is the first to explore new parents' attitudes toward newborn genomic testing. The findings suggest that if newborn genomic testing becomes available, there would be robust interest among new parents, regardless of their demographic background.
MEDai, Inc., an Elsevier company and leading provider of advanced solutions for healthcare that utilize award-winning predictive analytics, announced today that Novant Health, a not-for-profit integrated group of hospitals and physician practices, will roll out MEDai's Pinpoint Review(TM) to its nine hospitals in North Carolina, Virginia and South Carolina.
Excitement around the potential for targeted nanoparticles (NPs) that can be controlled by stimulus outside of the body for cancer therapy has been growing over the past few years. More specifically, there has been considerable attention around near-infrared (NIR) light as an ideal method to stimulate nanoparticles from outside the body.
› Verified 4 days ago
| Entity Name | Monmouth Cardiology Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285601674 PECOS PAC ID: 6901881200 Enrollment ID: O20040621001822 |
News Archive
IntraPace, Inc., the developer of the innovative abiliti implantable obesity management system, announced today that it will launch its new lifestyle management portal and support network this week at the XVI World Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) in Hamburg, Germany.
Publication in Nature Cell Biology advanced on line publication: researchers at the Université Libre de Bruxelles, ULB identify multipotent and unipotent Stem Cells (SCs) that contribute to prostate postnatal development.
A study published this week in Genetics in Medicine is the first to explore new parents' attitudes toward newborn genomic testing. The findings suggest that if newborn genomic testing becomes available, there would be robust interest among new parents, regardless of their demographic background.
MEDai, Inc., an Elsevier company and leading provider of advanced solutions for healthcare that utilize award-winning predictive analytics, announced today that Novant Health, a not-for-profit integrated group of hospitals and physician practices, will roll out MEDai's Pinpoint Review(TM) to its nine hospitals in North Carolina, Virginia and South Carolina.
Excitement around the potential for targeted nanoparticles (NPs) that can be controlled by stimulus outside of the body for cancer therapy has been growing over the past few years. More specifically, there has been considerable attention around near-infrared (NIR) light as an ideal method to stimulate nanoparticles from outside the body.
› Verified 4 days ago
| Entity Name | Meridian Cardiovascular Interpretive Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548310576 PECOS PAC ID: 8527012236 Enrollment ID: O20050307000039 |
News Archive
IntraPace, Inc., the developer of the innovative abiliti implantable obesity management system, announced today that it will launch its new lifestyle management portal and support network this week at the XVI World Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) in Hamburg, Germany.
Publication in Nature Cell Biology advanced on line publication: researchers at the Université Libre de Bruxelles, ULB identify multipotent and unipotent Stem Cells (SCs) that contribute to prostate postnatal development.
A study published this week in Genetics in Medicine is the first to explore new parents' attitudes toward newborn genomic testing. The findings suggest that if newborn genomic testing becomes available, there would be robust interest among new parents, regardless of their demographic background.
MEDai, Inc., an Elsevier company and leading provider of advanced solutions for healthcare that utilize award-winning predictive analytics, announced today that Novant Health, a not-for-profit integrated group of hospitals and physician practices, will roll out MEDai's Pinpoint Review(TM) to its nine hospitals in North Carolina, Virginia and South Carolina.
Excitement around the potential for targeted nanoparticles (NPs) that can be controlled by stimulus outside of the body for cancer therapy has been growing over the past few years. More specifically, there has been considerable attention around near-infrared (NIR) light as an ideal method to stimulate nanoparticles from outside the body.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jason David Litsky, DO 11 Meridian Rd, Eatontown, NJ 07724-2242 Ph: (732) 663-0300 | Jason David Litsky, DO 11 Meridian Rd, Eatontown, NJ 07724-2242 Ph: (732) 663-0300 |
News Archive
IntraPace, Inc., the developer of the innovative abiliti implantable obesity management system, announced today that it will launch its new lifestyle management portal and support network this week at the XVI World Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) in Hamburg, Germany.
Publication in Nature Cell Biology advanced on line publication: researchers at the Université Libre de Bruxelles, ULB identify multipotent and unipotent Stem Cells (SCs) that contribute to prostate postnatal development.
A study published this week in Genetics in Medicine is the first to explore new parents' attitudes toward newborn genomic testing. The findings suggest that if newborn genomic testing becomes available, there would be robust interest among new parents, regardless of their demographic background.
MEDai, Inc., an Elsevier company and leading provider of advanced solutions for healthcare that utilize award-winning predictive analytics, announced today that Novant Health, a not-for-profit integrated group of hospitals and physician practices, will roll out MEDai's Pinpoint Review(TM) to its nine hospitals in North Carolina, Virginia and South Carolina.
Excitement around the potential for targeted nanoparticles (NPs) that can be controlled by stimulus outside of the body for cancer therapy has been growing over the past few years. More specifically, there has been considerable attention around near-infrared (NIR) light as an ideal method to stimulate nanoparticles from outside the body.
› Verified 4 days ago
Violet Elizabeth Kramer, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 30 Corbett Way, Eatontown, NJ 07724 Phone: 732-380-0020 | |
Dr. Mariam Gamal Wassef, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 274 Route 35, Eatontown, NJ 07724 Phone: 732-440-7336 Fax: 732-440-9404 | |
Hank Ashforth, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 145 Wyckoff Rd Ste 301, Eatontown, NJ 07724 Phone: 848-208-5250 | |
Dr. Bharath Sathya, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 11 Meridian Rd, Eatontown, NJ 07724 Phone: 732-663-0300 Fax: 732-663-0301 | |
Dr. Jeffrey Osofsky, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 11 Meridian Rd, Eatontown, NJ 07724 Phone: 732-663-0300 Fax: 732-663-0301 | |
Dr. Charles Mattina, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 11 Meridian Rd, Eatontown, NJ 07724 Phone: 732-663-0300 Fax: 732-663-0301 |